Market Context — Why This Technology, Why Now

The global healthcare industry is undergoing a significant transformation driven by advancements in AI and the urgent need for greater efficiency and precision. Regulatory bodies are increasingly open to AI-powered diagnostic tools that demonstrate clinical efficacy and safety. Competitive dynamics demand that healthcare providers and medical device manufacturers integrate cutting-edge technologies to reduce operational costs, improve patient outcomes, and attract top talent. This technology aligns perfectly with the shift towards data-driven, personalized medicine and could enable providers to manage higher patient volumes with consistent, high-quality care.

Key Competitive Advantages
01

Increases diagnostic accuracy by up to 20% by identifying subtle changes often missed by conventional methods.

02

Reduces physician diagnosis time by 66% (to 1/3 of original time) by automating initial CT image interpretation.

03

Supports diagnosis for a wide range of nasal and paranasal sinus conditions, including complex cases like odontogenic maxillary sinusitis and maxillary cancer.

Market Opportunity
Medical Institutions & Hospitals
$600M–$700M globally (AI est.)
Improved efficiency and accuracy in CT image diagnosis directly translate to cost reduction in hospital management and enhanced patient satisfaction, indicating a high willingness to adopt this technology.
Large hospital networks and medical centers Specialized diagnostic imaging clinics Academic medical institutions
Health Check-ups & Preventive Medicine
$150M–$250M globally (AI est.)
As the importance of early detection and treatment grows, AI-supported screening creates new value for health check-up centers and preventive medical services.
Preventive care providers Health screening and wellness centers Corporate health programs
Medical Cloud Services
$100M–$200M globally (AI est.)
Offering this technology as a cloud-based diagnostic support service enables widespread deployment to small and medium-sized clinics and remote medical institutions, potentially expanding market reach.
Cloud-based EMR/PACS providers Telehealth and remote diagnostic platforms Medical AI software vendors
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a robust and difficult-to-invalidate scope, having overcome two office actions to secure grant, affirming its novelty and inventiveness. The claims cover the entire process from learning model generation to the diagnostic support system and data acquisition methods, ensuring comprehensive protection for the technology.

Competitive White Space

This patent primarily covers CT image analysis for nasal and paranasal sinus diagnosis. Adjacent white space includes applying similar AI methodologies to other imaging modalities or anatomical regions, and integrating diagnostic outputs with treatment planning systems or patient management platforms.

Economic Impact
~$200K/year estimated diagnostic cost reduction per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

By reducing physician diagnosis time per case from 20 minutes to 7 minutes (a 66% reduction) for an average of 1,000 cases annually, a facility could realize an estimated annual diagnostic cost reduction of ~$200K (AI est.). This calculation is based on the efficiency gains from reduced physician labor.

Speed to Market
8× faster than in-house development
This technology benefits from an established learning model generation method and detailed disclosure of the core diagnostic support system logic within the patent. This could reduce development time by approximately 3.5 years compared to building a similar AI diagnostic system from scratch. Key technical elements like CT image segmentation, quantification, and learning model input are clearly defined, allowing licensees to focus on integration with existing medical imaging systems and data, enabling rapid market entry.
Competitive Positioning

X: Diagnostic Accuracy and Objectivity
Y: Healthcare Professional Burden Reduction Effect

Business Models & Applications
☁️ SaaS-based Diagnostic Support Service
Offer AI-powered CT image analysis and diagnostic support features to medical institutions via a cloud-based monthly subscription model. Usage-based billing per diagnosis can also be integrated.
🔬 Embedded License for Medical Devices
License this technology's AI learning model and analysis algorithms to manufacturers of CT devices and PACS (Picture Archiving and Communication Systems), enhancing existing product value.
📊 Data Analysis & R&D Support
Provide automated CT image data analysis services for nasal and paranasal sinus diseases to pharmaceutical companies and research institutions, streamlining drug development and clinical research.
Adjacent Application Opportunities
🧠 Neurosurgery & Diagnostic Imaging
AI for Early Detection of Brain Lesions
The core CT image analysis, region segmentation, and lesion quantification technology could be adapted to automatically detect subtle brain lesions (e.g., tumors, aneurysms) from CT/MRI scans, potentially improving early diagnosis rates by 15-25%.
🦴 Orthopedics & Bone Diseases
AI for Bone Density & Fracture Risk Assessment
This technology could be applied to quantify bone structure and density changes from CT images. It could support osteoporosis diagnosis and identify high-risk fracture sites, potentially reducing misdiagnosis rates by 10-20% in orthopedics.
🔬 Pathology & Drug Discovery
Disease Biomarker Discovery via Tissue Image Analysis
The technology could be repurposed to segment and quantify specific cell morphologies or structures from pathological tissue or cell images. This could accelerate disease-specific biomarker discovery and drug efficacy screening by up to 30%.
Integration Roadmap — Estimated 12-Month Deployment
Phase 1: Technical Validation & Requirements Definition
Duration: 3 months
Evaluate integration potential with existing CT imaging systems and define requirements tailored to the licensee's specific diagnostic workflow. Conduct small-scale data validation using prototypes.
Phase 2: System Development & Model Optimization
Duration: 6 months
Develop the diagnostic support system based on defined requirements. Retrain and optimize the learning model using additional data held by the licensee to improve accuracy in real-world operating environments.
Phase 3: Pilot Deployment & Operation Launch
Duration: 3 months
Pilot the developed system in a real clinical setting to evaluate diagnostic accuracy, processing speed, and usability. Incorporate feedback from healthcare professionals and initiate full-scale operation.
Technical Feasibility
This technology, an AI learning model generation and diagnostic support system based on CT images, has high compatibility with existing medical imaging systems (e.g., PACS) and CT devices. The patent claims clearly describe the entire process from CT image acquisition to region segmentation, quantification, and learning model-based diagnosis. Implementation is primarily through software deployment and data integration. Utilizing general-purpose image processing and machine learning frameworks, relatively smooth system integration is anticipated without significant capital investment.
Success Scenario
Implementing this technology could dramatically streamline the diagnostic process for nasal and paranasal sinus diseases in medical institutions. AI would automatically analyze CT images and present potential lesions, reducing the physician's interpretation burden and significantly shortening diagnosis time. This could increase the number of patients seen daily and reduce patient waiting times. Furthermore, AI's objective numerical evaluation is estimated to enhance diagnostic consistency and accuracy, particularly aiding less experienced physicians, thereby contributing to the standardization of medical quality.
Patent Record
APPLICATION NO.
特願2024-014603
REGISTRATION NO.
7725783
FILING DATE
2024/02/02
GRANT DATE
2025/08/12
EXPIRATION DATE
2044/02/02
PATENT HOLDER
国立大学法人福井大学
Examination History
2024年02月15日
出願審査請求書
2024年09月03日
拒絶理由通知書
2024年12月27日
意見書
2024年12月27日
手続補正書（自発・内容）
2025年02月18日
拒絶理由通知書
2025年06月17日
手続補正書（自発・内容）
2025年06月17日
意見書
2025年07月08日
特許査定